TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
फ़र. ०६, २०२६
2 min read
7

Financial services firm UBS forecasts a gradual appreciation of the British pound against the Swiss franc (GBP/CHF). The projection is based on an expected reversal of safe-haven flows into the franc and strong fundamental support for sterling, coupled with positive UK economic data.
The Swiss franc recently benefited from increased demand as a safe-haven asset. However, UBS currency analysis suggests this trend will reverse in the coming months. Simultaneously, a previously priced-in budget-related risk premium has been eliminated from the British pound, providing additional stability and support for the currency.
A critical factor driving the forecast is the significant yield differential, which currently exceeds 3.5% in favor of the pound. This advantage makes holding sterling more attractive for investors seeking returns compared to the lower-yielding Swiss franc. According to UBS, this fundamental aspect provides a strong basis for the expected appreciation in the GBP/CHF pair.
With safe-haven demand for the Swiss franc expected to diminish and a compelling yield advantage for the pound, UBS anticipates a steady upward trajectory for the GBP/CHF spot exchange rate. Traders will closely watch economic indicators from both nations to confirm this trend.
Q: Why is the GBP/CHF exchange rate expected to rise?
A: UBS predicts a rise due to waning safe-haven demand for the Swiss franc, positive UK economic data, and a significant yield differential of over 3.5% favoring the British pound.
Q: What does the yield differential signify for investors?
A: The higher yield on the British pound makes it a more attractive currency for investors to hold for returns compared to the Swiss franc, which can drive capital flows into the pound and increase its value.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

०६ फ़र. २०२६
Novo Nordisk Stock Soars on FDA Drug Crackdown

०६ फ़र. २०२६
LNA Santé Exceeds FY25 Targets, Eyes €1B by 2027